ReviewWorld journal of clinical pediatrics2018
Controversies in diagnosis and management of Kawasaki disease.
Review in World journal of clinical pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 59 citations in OpenAlex.
- Natural history and long-term outcomes of kawasaki disease following spontaneous defervescence: 31 years of experience from North India.Immunologic research · 2026Article
- Incomplete Kawasaki Disease Presenting With Coronary Artery Aneurysms in a 2.5-Month-Old Infant: A Case Report.Cureus · 2026Article
- Cardiac arrest as initial presentation of Kawasaki disease with giant coronary aneurysms: A case report and review of literature.World journal of clinical cases · 2025Article
- Exploring the role of exosomal and non-exosomal non-coding RNAs in Kawasaki disease: Implications for diagnosis and therapeutic strategies against coronary artery aneurysms.Biochemistry and biophysics reports · 2025Review
- Imperative for long-term management and surveillance in Kawasaki disease.World journal of clinical cases · 2025Article
- Kawasaki disease: insights into the roles of T cells.Frontiers in immunology · 2025Review
- Ubiquitin ligase MDM2 mediates endothelial inflammation in Kawasaki disease vasculitis development.Translational pediatrics · 2024Article
- Dilemma in diagnosing incomplete Kawasaki disease in a resource limited setting.Annals of medicine and surgery (2012) · 2023Article
- Radiation dose analysis of computed tomography coronary angiography in Children with Kawasaki disease.World journal of clinical pediatrics · 2023Article
- Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease.Clinical and experimental medicine · 2023Article
- Emerging role of computed tomography coronary angiography in evaluation of children with Kawasaki disease.World journal of clinical pediatrics · 2023Review
- Article
- Kawasaki disease and the environment: an enigmatic interplay.Frontiers in immunology · 2023Review
- Association of single nucleotide polymorphism rs113420705 ofJournal of family medicine and primary care · 2022Article
- Incidence of chronic immune-mediated inflammatory diseases after diagnosis with Kawasaki disease: a population-based cohort study.Rheumatology (Oxford, England) · 2022Article
- Article
- Hydrocele in a case of atypical Kawasaki disease: case report and review of diagnostic criteria.BMC pediatrics · 2021Article
- The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C).Rheumatology international · 2021Review
- Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.Rheumatology international · 2021Review
- Acute cholestasis as uncommon onset of Kawasaki disease: a case report.BMC gastroenterology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kawasaki disease (KD) is a common medium vessel systemic vasculitis that usually occurs in small children. It has a predilection for the coronary arteries, but other medium sized arteries can also be involved. The etiology of this disorder remains a mystery. Though typical presentation of KD is quite characteristic, it may also present as incomplete or atypical disease in which case the diagnosis can be very challenging. As both incomplete and atypical forms of KD can be associated with serious coronary artery complications, the pediatrician can ill afford to miss these diagnoses. The American Heart Association has enunciated consensus guidelines to facilitate the clinical diagnosis and treatment of this condition. However, there are still several issues that remain controversial. Intravenous immunoglobulin remains the cornerstone of management but several other treatment modalities, especially glucocorticoids, are increasingly finding favour. We review here some of the contemporary issues, and the controversies thereon, pertaining to management of KD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.